Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE

Mira Mousa; Mohammed Albreiki; Fatima Alshehhi; Safiya AlShamsi; Nada Al Marzouqi; Tayba Alawadi; Hussain Alrand; Habiba Alsafar; Asma Fikri

doi:10.1093/jtm/taac036

Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE

Mira Mousa, Mohammed Albreiki, Fatima Alshehhi, Safiya AlShamsi, Nada Al Marzouqi, Tayba Alawadi, Hussain Alrand, Habiba Alsafar, Asma Fikri

Biomedical Engineering & Biotechnology

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Original language	British English
Journal	Journal of travel medicine
Volume	29
Issue number	6
DOIs	https://doi.org/10.1093/jtm/taac036
State	Published - 17 Sep 2022

Keywords

B.1.617.2
BBIBP-CorV
BNT162b2
COVID-19
Delta
SARS-CoV-2
vaccine effectiveness

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/jtm/taac036

Cite this

Mousa, M., Albreiki, M., Alshehhi, F., AlShamsi, S., Marzouqi, N. A., Alawadi, T., Alrand, H., Alsafar, H., & Fikri, A. (2022). Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE. Journal of travel medicine, 29(6). https://doi.org/10.1093/jtm/taac036

@article{53b62ab41bb64503b0e840021342a13c,

title = "Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE",

keywords = "B.1.617.2, BBIBP-CorV, BNT162b2, COVID-19, Delta, SARS-CoV-2, vaccine effectiveness",

author = "Mira Mousa and Mohammed Albreiki and Fatima Alshehhi and Safiya AlShamsi and Marzouqi, {Nada Al} and Tayba Alawadi and Hussain Alrand and Habiba Alsafar and Asma Fikri",

year = "2022",

month = sep,

day = "17",

doi = "10.1093/jtm/taac036",

language = "British English",

volume = "29",

journal = "Journal of travel medicine",

issn = "1708-8305",

publisher = "Oxford University Press",

number = "6",

}

Mousa, M, Albreiki, M, Alshehhi, F, AlShamsi, S, Marzouqi, NA, Alawadi, T, Alrand, H, Alsafar, H & Fikri, A 2022, 'Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE', Journal of travel medicine, vol. 29, no. 6. https://doi.org/10.1093/jtm/taac036

Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE. / Mousa, Mira; Albreiki, Mohammed; Alshehhi, Fatima et al.
In: Journal of travel medicine, Vol. 29, No. 6, 17.09.2022.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE

AU - Mousa, Mira

AU - Albreiki, Mohammed

AU - Alshehhi, Fatima

AU - AlShamsi, Safiya

AU - Marzouqi, Nada Al

AU - Alawadi, Tayba

AU - Alrand, Hussain

AU - Alsafar, Habiba

AU - Fikri, Asma

PY - 2022/9/17

Y1 - 2022/9/17

KW - B.1.617.2

KW - BBIBP-CorV

KW - BNT162b2

KW - COVID-19

KW - Delta

KW - SARS-CoV-2

KW - vaccine effectiveness

UR - http://www.scopus.com/inward/record.url?scp=85138458512&partnerID=8YFLogxK

U2 - 10.1093/jtm/taac036

DO - 10.1093/jtm/taac036

M3 - Article

C2 - 35244687

AN - SCOPUS:85138458512

SN - 1708-8305

VL - 29

JO - Journal of travel medicine

JF - Journal of travel medicine

IS - 6

ER -

Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE

Keywords

UN SDGs

Access to Document

Other files and links

Cite this